m+Medelevator.RU
← Поиск публикаций
Nature communications · 2026

HELZ-BRCA2 complex resolves R-loops to drive transcription-coupled homologous recombination.

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Li Wenjing, Wu Bo, Gao Boya, Irvin Elizabeth M, Ghosh Arijit, Eliaz Lillian, Huang Yuxin, Kwon Youngho, Stiefel Clara M, Nguyen Tram Thi Ngoc, Zhao David, Suarez Humberto Javier, Ni Tengyang, Alejo Salvador, Fitzgerald O'Taveon, Song Xuemei, Rath Sandip Kumar, Wasmuth Elizabeth V, Yu David S, Zheng Siyuan, Leung Justin, Xue Xiaoyu, Wang Hong, Ji Jae-Hoon, Lan Li, Zhao Weixing

Аннотация

R-loops are transcription-induced, three-stranded nucleic acid structures that, if not properly resolved, can disrupt DNA repair and compromise genome stability. BRCA2, a tumor suppressor vital for homologous recombination (HR), also contributes to R-loop regulation, though the underlying mechanisms remain poorly understood. Here, we identify HELZ as a direct BRCA2 interactor and characterize it as an ssRNA-specific R-loop resolvase. BRCA2 enhances HELZ helicase activity and promotes its recruitment to R-loops. Importantly, HELZ resolves R-loops at DNA double-strand breaks, enabling efficient DNA end resection and HR, particularly within transcriptionally active genomic regions. We further demonstrate that HELZ is critical for R-loop clearance in cancers with elevated transcriptional activity and R-loop accumulation, such as estrogen receptor-positive breast cancer, where it becomes essential for cell survival under estrogen-induced transcriptional stress. These findings establish HELZ as a BRCA2-dependent regulator of R-loop homeostasis and identify it as a potential biomarker and therapeutic target in R-loop-driven malignancies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты